New press release out: HCS Pharma, LumiSTAR Biotech & MolDev explore stem cell-derived organoids for drug screening

In Asia for a business trip, Nathalie Maubon, PhD, CEO & CSO of HCS Pharma, participated in a symposium during BioAsia event on late July, together with LumiSTAR Biotechnology (Taïwan) and Molecular Devices (USA). On this occasion, the 3 companies have highlighted their work on hiPSCs (human induced Pluripotent Stem Read more…

Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models

We are very happy to invite you to our next webinar about 3D cellular cancer models and our BIOMIMESYS® Oncology matrix which allows cancer cells to be cultured in a tumor-like environment, with the possibility to tune the composition and stiffness of the matrix. We will also share our best Read more…

Join us at Molecular Devices workshop on innovative 3D methods for HCS, March 16-17, 2021

During the next Molecular Devices online event called “From organoids to cell painting: Investigate 3D and complex biology using advanced methods in high-content cellular imaging and analysis” we will present how to generate functional human liver organoids derived from hiPSC in BIOMIMESYS® hydroscaffold. This virtual user meeting and workshop is Read more…